Literature DB >> 6180986

Mediators of protection against lethal systemic vesicular stomatitis virus infection in hamsters: defective interfering particles, polyinosinate-polycytidylate, and interferon.

P N Fultz, J A Shadduck, C Y Kang, J W Streilein.   

Abstract

Homologous defective interfering (DI) particles protected adult Syrian hamsters against lethal systemic infection with vesicular stomatitis virus (VSV) serotype Indiana. The DI particles had to be biologically active, but did not have to be administered at the same inoculation site as the infectious virus. Serum and tissue levels of VSV postinoculation were significantly lower in DI-protected animals than in unprotected controls, suggesting that true autointerference was occurring. However, some aspects of protection also must be mediated through nonspecific mechanisms, since susceptible hamsters could be protected against VSV Indiana by coinjection with heterologous DI particles prepared from VSV serotype New Jersey or by simultaneous administration of polyinosinic acid-polycytidylic acid. By measuring serum levels of putative hamster interferon (type 1), we found that animals coinjected with VSV and DI particles or polyinosinic acid-polycytidylic acid produced significant levels of interferon. Since similarly high serum levels of interferon were measured in recipients of VSV alone (animals that eventually died from infection), there appeared to be no correlation between protection against lethal disease and induced levels of serum interferon. Instead, serum interferon levels correlated positively with amounts of VSV PFU found in serum and tissues of infected animals, the lowest levels being found in serum of animals protected with homologous DI particles. The data are consistent with the hypothesis that autointerference by DI particles as well as various host defense mechanisms (possibly including induction of interferon) participates in protecting hamsters against lethal VSV infection.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6180986      PMCID: PMC347585          DOI: 10.1128/iai.37.2.679-686.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Efficacy of exogenous interferon treatment initiated after onset of multiplication of vesicular stomatitis virus in the brains of mice.

Authors:  I Gresser; M G Tovey; C Bourali-Maury
Journal:  J Gen Virol       Date:  1975-06       Impact factor: 3.891

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Prophylaxis and immunization in mice by use of virus-free defective T particles to protect against intracerebral infection by vesicular stomatitis virus.

Authors:  M Doyle; J J Holland
Journal:  Proc Natl Acad Sci U S A       Date:  1973-07       Impact factor: 11.205

4.  Serological relationships between different strains of vesicular stomatis virus.

Authors:  B Cartwright; F Brown
Journal:  J Gen Virol       Date:  1972-09       Impact factor: 3.891

5.  Effect of antiviral agents in equine abortion virus-infected hamsters.

Authors:  M Lieberman; A Pascale; T W Schafer; P E Came
Journal:  Antimicrob Agents Chemother       Date:  1972-02       Impact factor: 5.191

6.  Defective viral particles and viral disease processes.

Authors:  A S Huang; D Baltimore
Journal:  Nature       Date:  1970-04-25       Impact factor: 49.962

7.  Interferon and haemopoietic colony inhibitor responses to poly I-poly C in rabbits and hamsters.

Authors:  T A McNeill; W A Fleming; D J McCance
Journal:  Immunology       Date:  1972-05       Impact factor: 7.397

8.  Interferon induction and sensitivity as correlates to virulence of Venezuelan encephalitis viruses for hamsters.

Authors:  P B Jahrling; E Navarro; W F Scherer
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

9.  Effect of poly I: C on experimental respiratory infection in hamsters.

Authors:  H E Renis
Journal:  Appl Microbiol       Date:  1970-11

10.  Generation of defective virus after infection of newborn rats with reovirus.

Authors:  D A Spandidos; A F Graham
Journal:  J Virol       Date:  1976-10       Impact factor: 5.103

View more
  7 in total

Review 1.  Defective interfering influenza virus RNAs: time to reevaluate their clinical potential as broad-spectrum antivirals?

Authors:  Nigel J Dimmock; Andrew J Easton
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

2.  Early and strong immune responses are associated with control of viral replication and recovery in lassa virus-infected cynomolgus monkeys.

Authors:  Sylvain Baize; Philippe Marianneau; Philippe Loth; Stéphanie Reynard; Alexandra Journeaux; Michèle Chevallier; Noël Tordo; Vincent Deubel; Hugues Contamin
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

3.  Development of recombinant vesicular stomatitis viruses that exploit defects in host defense to augment specific oncolytic activity.

Authors:  Masatsugu Obuchi; Marilyn Fernandez; Glen N Barber
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

4.  Pathogenesis of mucosal disease: a cytopathogenic pestivirus generated by an internal deletion.

Authors:  N Tautz; H J Thiel; E J Dubovi; G Meyers
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

5.  A defective interference-like phenomenon of human hepatitis B virus in chronic carriers.

Authors:  T T Yuan; M H Lin; D S Chen; C Shih
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

6.  Temozolomide hexadecyl ester targeted plga nanoparticles for drug-resistant glioblastoma therapy via intranasal administration.

Authors:  Siqi Wang; Yawen Yu; Aiping Wang; Xinliu Duan; Yuchen Sun; Liangxiao Wang; Liuxiang Chu; Yanan Lv; Nan Cui; Xuesong Fan; Chunjie Sha; Lixiao Xu; Kaoxiang Sun
Journal:  Front Pharmacol       Date:  2022-08-17       Impact factor: 5.988

7.  A Surrogate Animal Model for Screening of Ebola and Marburg Glycoprotein-Targeting Drugs Using Pseudotyped Vesicular Stomatitis Viruses.

Authors:  Takeshi Saito; Junki Maruyama; Noriyo Nagata; Mao Isono; Kosuke Okuya; Yoshihiro Takadate; Yurie Kida; Hiroko Miyamoto; Akina Mori-Kajihara; Takanari Hattori; Wakako Furuyama; Shinya Ogawa; Shigeru Iida; Ayato Takada
Journal:  Viruses       Date:  2020-08-22       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.